This supports our suggestion that altered DNA methylation in FADS2 contributes primarily to altered desaturase activity and possibly liver steatosis in NAFLD, and not to liver inflammation or fibrosis. The gene discussed is FADS2; the disease is metabolic dysfunction-associated steatotic liver disease.